[Corrigendum] Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer
- Authors:
- Published online on: May 30, 2016 https://doi.org/10.3892/ijo.2016.3545
- Pages: 848-848
-
Copyright: © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article
Downregulation of cytokeratin 18 is associated with paclitaxel-resistance and tumor aggressiveness in prostate cancer
BO YIN, MO ZHANG, YU ZENG, YOUQIANG LI, CHAO ZHANG, YONGSHENG SONG
[Related article:] Int J Oncol 48: 1730–1736, 2016; DOI: 10.3892/ijo.2016.3396
After the publication of the article, the authors noted that they would like to add Dr Robert H. Getzenberg's name to the authors' list and as a co-corresponding author, upon the agreement of all the authors. The correct author list should be as follows:
BO YIN1, MO ZHANG1, YU ZENG2,3*, YOUQIANG LI3, CHAO ZHANG1, ROBERT H. GETZENBERG3* and YONGSHENG SONG1*
1Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004; 2Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China; 3James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21087, USA
Correspondence should now be addressed to: Correspondence to: Dr Yongsheng Song, Department of Urology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, Liaoning 110004, P.R. China, E-mail: yinbowzf@163.com
Dr Robert H. Getzenberg, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21087, USA, E-mail: getzenberg@outlook.com
*Contributed equally